(Q42210002)

18 October 2017

Fuchsin acid selectively inhibits human immunodeficiency virus (HIV) replication in vitro (English)

1 reference

18 October 2017

Baba M

1

1 reference

18 October 2017

Schols D

2

1 reference

18 October 2017

Pauwels R

3

1 reference

18 October 2017

Balzarini J

4

1 reference

18 October 2017

De Clercq E

5

1 reference

18 October 2017

1 September 1988

1 reference

Biochemical and Biophysical Research Communications

18 October 2017

1 reference

18 October 2017

155

1 reference

18 October 2017

3

1 reference

18 October 2017

1404-1411

1 reference

Isolation of human T-cell leukemia virus in acquired immune deficiency syndrome (AIDS)

18 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Isolation of a T-Lymphotropic Retrovirus from a Patient at Risk for Acquired Immune Deficiency Syndrome (AIDS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Functional Properties of Antigen-Specific T Cells Infected by Human T-Cell Leukemia-Lymphoma Virus (HTLV-I)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Effects of suramin on HTLV-III/LAV infection presenting as Kaposi's sarcoma or AIDS-related complex: clinical pharmacology and suppression of virus replication in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

The toxicity of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Resumption of HIV antigen production during continuous zidovudine treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Infection of HTLV-III/LAV in HTLV-I-carrying cells MT-2 and MT-4 and application in a plaque assay

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Isolation of Lymphocytopathic Retroviruses from San Francisco Patients with AIDS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Role of thymidine kinase in the inhibitory activity of 5-substituted-2'-deoxyuridines on the growth of human and murine tumor cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Aurintricarboxylic acid and Evans Blue represent two different classes of anionic compounds which selectively inhibit the cytopathogenicity of human T-cell lymphotropic virus type III/lymphadenopathy-associated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Sensitive and rapid assay on MT-4 cells for detection of antiviral compounds against the AIDS virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Dextran sulfate suppression of viruses in the HIV family: inhibition of virion binding to CD4+ cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

Comparative inhibitory effects of suramin and other selected compounds on the infectivity and replication of human T-cell lymphotropic virus (HTLV-III)/lymphadenopathy-associated virus (LAV)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-291X%2888%2981297-X

10.1016/S0006-291X(88)81297-X

7 January 2021

Identifiers

DOI

1 reference

18 October 2017

1 reference